News

September 24, 2018September 24, 2018

Roche Set to Start 2 Clinical Studies of Potential Huntington’s Therapy RG6042

News

Two new clinical studies of Roche’s investigational therapy RG6042 for Huntington’s disease (HD) are planned to start by the end of 2018 and will begin enrolling participants by early 2019. These ... Read more

September 21, 2018September 21, 2018

#NORDSummit – More Than 700 Expected to Attend Oct. 15-16 Rare Disease Summit in Washington

News

More than 700 medical experts, pharmaceutical executives, patient advocates, and others are expected to converge on Washington, D.C., next month for the 2018 NORD Rare Diseases & Orphan Products ... Read more

September 19, 2018September 19, 2018

Metformin Reversed Symptoms Associated with Huntington’s Disease in Mouse Study

News

Researchers narrowing in on early neuronal functioning stages of development, well before Huntington’s disease symptoms appear, believe they have found a potentially important path to intervening with the diabetes medication metformin. Their ... Read more

September 18, 2018September 18, 2018

New Test Could Help Predict Onset, Course of Huntington’s, Lab Researchers Say

News

Short huntingtin (HTT) protein fibers precede the formation of larger deposits that accumulate in the brains of those affected by Huntington’s disease, preclinical results reveal. These findings one day may ... Read more

September 13, 2018September 13, 2018

Early Therapeutic Intervention Seen to Reverse Huntington’s Symptoms in Mouse Study

News

Huntington’s disease begins early, before birth, but symptoms tend to appear much later in life. Now, researchers working with mice have found a way to reverse so-called “pre-Huntington’s symptoms,” ... Read more

September 11, 2018September 11, 2018

Active Biotech Regains Rights to Laquinimod to Continue Studying Its Potential

News

Active Biotech. has regained global development and commercialization rights of laquinimod, an investigational immunotherapy for neurodegenerative diseases, including Huntington’s disease (HD) and multiple sclerosis (MS). The move came after Teva Pharmaceutical, ... Read more

September 6, 2018September 6, 2018

Time Perception Impaired in Huntington’s Patients, and Linked to Disease Severity, Study Finds

News

Time perception is impaired in patients with Huntington’s disease, even in pre- or early-symptomatic stages of the disease, and is correlated with disease severity and progression, Swiss researchers found. ... Read more

September 4, 2018September 4, 2018

Autophagy Affects Protein Accumulation, Gene Activity in Huntington’s, Study Finds

News

Researchers have found a direct link between abnormal protein accumulation in nerve cells — a hallmark of several neurodegenerative diseases, such as Parkinson’s and Alzheimer’s — and the regulation ... Read more

August 30, 2018August 30, 2018

Salivary Uric Acid a Valid Biomarker for Wide Range of Conditions, Including Huntington’s, Study Finds

News

Salivary uric acid is a valid biomarker for a wide range of potential conditions and disease states, including Huntington’s disease, according to a recent study. The study, “The validity, ... Read more

August 28, 2018August 28, 2018

MMJ Files Application With FDA to Begin Clinical Trial of Cannabis-Based Meds to Treat Huntington’s

News

MMJ International has filed two applications with the U.S. Food and Drug Administration (FDA) requesting permission to begin clinical studies to test its pharmaceutical grade cannabis-based therapies in easing symptoms ... Read more

Pin It on Pinterest